SC 13G
NEA 15 / CRISPR THERAPEUTICS AG - 13G
- Company
- CRISPR Therapeutics AG
- Filed
- February 6, 2017
- Accession Number
- 0001072613-17-000056
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →